Mylan Adds to U.S. Women’s Healthcare Portfolio With FDA Approval of First Generic for Estrace® Cream

December 29, 2017

Responsive image

HERTFORDSHIRE, England and PITTSBURGH, Dec. 29, 2017 /PRNewswire/ — Global pharmaceutical leader Mylan N.V. (NASDAQ, TASE: MYL) today announced the U.S. launch of Estradiol Vaginal Cream USP, 0.01%, the first generic version of Allergan’s Estrace® Cream. Mylan received final approval…

Category: Precious Metals